GIP
AGTC

Granite Investment Partners’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Granite Investment Partners’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-73,543
Closed -$375K – 317
2017
Q2 		$375K Sell
73,543
-3,545
-5% -$19.9K 0.03% 283
2017
Q1 		$532K Sell
77,088
-3,032
-4% -$23.7K 0.04% 275
2016
Q4 		$749K Buy
+80,120
New +$722K 0.06% 257

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Granite Investment Partners's AGTC Position: Q3 2017 in Review

Granite Investment Partners sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2017, closing a stake of 73,543 shares — an estimated $375K sold.

Granite Investment Partners first reported a position in AGTC in Q4 2016 and held it in 3 quarters. The position peaked at $749K in Q4 2016. 67 funds tracked by Wall St. Rank hold AGTC as of Q3 2017.

  • Granite Investment Partners reported no remaining Applied Genetic Technologies Corporation position as of Q3 2017 after selling out during the quarter.
  • Granite Investment Partners sold 73,543 Applied Genetic Technologies Corporation shares in Q3 2017, an estimated $375K.
  • Granite Investment Partners first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 3 quarters.
  • Granite Investment Partners's Applied Genetic Technologies Corporation position peaked at $749K in Q4 2016.
  • 67 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2017.

Based on Granite Investment Partners's 13F filing for Q3 2017, filed 8 Nov 2017.